Health Care·Life Sciences Tools & Services·$32.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.15 | N/A | +41.51% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.15 | N/A | +41.51% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a cautiously optimistic outlook despite market challenges. They emphasized their focus on operational efficiency.
Management highlighted strong performance in key segments.
They noted ongoing challenges in the market but expressed confidence in their strategies.
Agilent Technologies reported a positive surprise in EPS, exceeding expectations significantly. However, the stock fell by 2.0% in reaction, likely due to the lack of revenue data and guidance. Investors may be concerned about the broader market conditions mentioned by management.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
PETROLEO BRASILEIRO ADR
Aug 15, 2009